Blastic Plasmacytoid Dendritic Cell Neoplasm research hub

Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN

This study is testing a new medicine called IMGN632 for people with certain types of blood cancers, including a rare one called BPDCN. We're looking at how safe it is, how well it's tolerated, and if it helps fight the cancer.